This technology describes a distinct class of ibogaine analogs created by chemical synthesis that maintains the pharmacological benefits of ibogaine with reduced cardiac adverse effects.

This technology is an automated, AI-based platform for identifying and segmenting ductal carcinoma in situ (DCIS) lesions on breast MRI.

This technology is a fully integrated holographic microscope system capable of simultaneous, high-resolution imaging and precise stimulation of 3D neuronal circuits using optogenetics.